RiverPark Advisors reports strong Q2 for Long/Short Fund, led by AI-driven longs like NVIDIA and Microsoft. See how the ...

A clinical trial of the drug Trontinemab will aim to delay or prevent the symptoms of Alzheimer's disease, Swiss drugmaker Roche says.